The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Beyond intestinal soap—bile acids in metabolic control
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The gut microbiota--masters of host development and physiology
Sommer, F., & Bäckhed, F. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2974 · Cited by 3,681
Gut metagenome in European women with normal, impaired and diabetic glucose control
Karlsson, F. H., Tremaroli, V., Nookaew, I., Bergström, G., Behre, C. J., Fagerberg, B., Nielsen, J., & Bäckhed, F. (2013) · Nature · doi:10.1038/nature12198 · Cited by 3,115
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Sayin, S. I., Wahlström, A., Felin, J., Jäntti, S., Marschall, H.-U., Bamberg, K., Angelin, B., Hyötyläinen, T., Orešič, M., & Bäckhed, F. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.01.003 · Cited by 2,331
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
Watanabe, M., Houten, S. M., Mataki, C., Christoffolete, M. A., Kim, B. W., Sato, H., Messaddeq, N., Harney, J. W., Ezaki, O., Kodama, T., et al. (2006) · Nature · doi:10.1038/nature04330 · Cited by 2,220
FGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125
The Enzymes, Regulation, and Genetics of Bile Acid Synthesis
Russell, D. W. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161712 · Cited by 2,069
TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
Thomas, C., Gioiello, A., Noriega, L., Strehle, A., Oury, J., Rizzo, G., Macchiarulo, A., Yamamoto, H., Mataki, C., Pruzanski, M., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.08.001 · Cited by 1,885
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865
Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
Lefebvre, P., Cariou, B., Lien, F., Kuipers, F., & Staels, B. (2009) · Physiological Reviews · doi:10.1152/physrev.00010.2008 · Cited by 1,678
Self-citationEndogenous Bile Acids Are Ligands for the Nuclear Receptor FXR/BAR
Wang, H., Chen, J., Hollister, K., Sowers, L. C., & Forman, B. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80348-2 · Cited by 1,636
A G Protein-coupled Receptor Responsive to Bile Acids
Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628
Targeting bile‐acid signalling for metabolic diseases
Thomas, C., Pellicciari, R., Pruzanski, M., Auwerx, J., & Schoonjans, K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2619 · Cited by 1,422
Pleiotropic Roles of Bile Acids in Metabolism
de Aguiar Vallim, T. Q., Tarling, E. J., & Edwards, P. A. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.03.013 · Cited by 1,209
Vitamin D Receptor As an Intestinal Bile Acid Sensor
Makishima, M., Lu, T. T., Xie, W., Whitfield, G. K., Domoto, H., Evans, R. M., Haussler, M. R., & Mangelsdorf, D. J. (2002) · Science · doi:10.1126/science.1070477 · Cited by 1,176
Xu, J., Lloyd, D. J., Hale, C., Stanislaus, S., Chen, M., Sivits, G., Vonderfecht, S., Hecht, R., Li, Y.-S., Lindberg, R. A., et al. (2009) · Diabetes · doi:10.2337/db08-0392 · Cited by 1,151
Fibroblast Growth Factor 21 Corrects Obesity in Mice
Coskun, T., Bina, H. A., Schneider, M. A., Dunbar, J. D., Hu, C. C., Chen, Y., Moller, D. E., & Kharitonenkov, A. (2008) · Endocrinology · doi:10.1210/en.2008-0816 · Cited by 1,031
Identification of membrane-type receptor for bile acids (M-BAR)
Maruyama, T., Miyamoto, Y., Nakamura, T., Tamai, Y., Okada, H., Sugiyama, E., Nakamura, T., Itadani, H., & Tanaka, K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02550-0 · Cited by 993
Commensal bacteria at the interface of host metabolism and the immune system
Brestoff, J. R., & Artis, D. (2013) · Nature Immunology · doi:10.1038/ni.2640 · Cited by 945
Mudaliar, S., Henry, R. R., Sanyal, A. J., Morrow, L., Marschall, H., Kipnes, M., Adorini, L., Sciacca, C. I., Clopton, P., Castelloe, E., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.05.042 · Cited by 931
Kurosu, H., Choi, M., Ogawa, Y., Dickson, A. S., Goetz, R., Eliseenkova, A. V., Mohammadi, M., Rosenblatt, K. P., Kliewer, S. A., & Kuro-o, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704165200 · Cited by 748
Systemic gut microbial modulation of bile acid metabolism in host tissue compartments
Swann, J. R., Want, E. J., Geier, F. M., Spagou, K., Wilson, I. D., Sidaway, J. E., Nicholson, J. K., & Holmes, E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006734107 · Cited by 726
Li, F., Jiang, C., Krausz, K. W., Li, Y., Albert, I., Hao, H., Fabre, K. M., Mitchell, J. B., Patterson, A. D., & Gonzalez, F. J. (2013) · Nature Communications · doi:10.1038/ncomms3384 · Cited by 705
Potthoff, M. J., Inagaki, T., Satapati, S., Ding, X., He, T., Goetz, R., Mohammadi, M., Finck, B. N., Mangelsdorf, D. J., Kliewer, S. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904187106 · Cited by 704
Bile acid receptors as targets for drug development
Schaap, F. G., Trauner, M., & Jansen, P. L. M. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.151 · Cited by 696
Overview of nomenclature of nuclear receptors
Germain, P., Staels, B., Dacquet, C., Spedding, M., & Laudet, V. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.4.2 · Cited by 688
FGF19 as a Postprandial, Insulin-Independent Activator of Hepatic Protein and Glycogen Synthesis
Kir, S., Beddow, S. A., Samuel, V. T., Miller, P., Previs, S. F., Suino-Powell, K., Xu, H. E., Shulman, G. I., Kliewer, S. A., & Mangelsdorf, D. J. (2011) · Science · doi:10.1126/science.1198363 · Cited by 637
Patti, M., Houten, S. M., Bianco, A. C., Bernier, R., Larsen, P. R., Holst, J. J., Badman, M. K., Maratos‐Flier, E., Mun, E. C., Pihlajamaki, J., et al. (2009) · Obesity · doi:10.1038/oby.2009.102 · Cited by 591
Meier, P. J., & Stieger, B. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.082201.100300 · Cited by 586
Metabolic Footprint of Diabetes: A Multiplatform Metabolomics Study in an Epidemiological Setting
Suhre, K., Meisinger, C., Döring, A., Altmaier, E., Belcredi, P., Gieger, C., Chang, D., Milburn, M. V., Gall, W. E., Weinberger, K. M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013953 · Cited by 556
The Farnesoid X Receptor Modulates Adiposity and Peripheral Insulin Sensitivity in Mice
Cariou, B., van Harmelen, K., Duran-Sandoval, D., van Dijk, T. H., Grefhorst, A., Abdelkarim, M., Caron, S., Torpier, G., Fruchart, J.-C., Gonzalez, F. J., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510258200 · Cited by 552
Self-citationEndocrine fibroblast growth factors 15/19 and 21: from feast to famine
Potthoff, M. J., Kliewer, S. A., & Mangelsdorf, D. J. (2012) · Genes & Development · doi:10.1101/gad.184788.111 · Cited by 442
FGF15/19 Regulates Hepatic Glucose Metabolism by Inhibiting the CREB-PGC-1α Pathway
Potthoff, M. J., Boney-Montoya, J., Choi, M., He, T., Sunny, N. E., Satapati, S., Suino-Powell, K., Xu, H. E., Gerard, R. D., Finck, B. N., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.019 · Cited by 431
LUNDÅSEN, T., GÄLMAN, C., ANGELIN, B., & RUDLING, M. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01731.x · Cited by 405
Bile acid transporters and regulatory nuclear receptors in the liver and beyond
Halilbasic, E., Claudel, T., & Trauner, M. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.08.002 · Cited by 393
Pournaras, D. J., Glicksman, C., Vincent, R. P., Kuganolipava, S., Alaghband-Zadeh, J., Mahon, D., Bekker, J. H. R., Ghatei, M. A., Bloom, S. R., Walters, J. R. F., et al. (2012) · Endocrinology · doi:10.1210/en.2011-2145 · Cited by 383
Robinson, J. G., Wang, S., Smith, B. J., & Jacobson, T. A. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.10.024 · Cited by 368
Fifty years of advances in bile acid synthesis and metabolism
Russell, D. W. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800026-jlr200 · Cited by 358
Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea
Sato, H., Genet, C., Strehle, A., Thomas, C., Lobstein, A., Wagner, A., Mioskowski, C., Auwerx, J., & Saladin, R. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.06.130 · Cited by 340
Kemper, J. K., Xiao, Z., Ponugoti, B., Miao, J., Fang, S., Kanamaluru, D., Tsang, S., Wu, S.-Y., Chiang, C.-M., & Veenstra, T. D. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.09.009 · Cited by 332
Farnesoid X Receptor Deficiency Improves Glucose Homeostasis in Mouse Models of Obesity
Prawitt, J., Abdelkarim, M., Stroeve, J. H. M., Popescu, I., Duez, H., Velagapudi, V. R., Dumont, J., Bouchaert, E., van Dijk, T. H., Lucas, A., et al. (2011) · Diabetes · doi:10.2337/db11-0030 · Cited by 326
Self-citationThe enterohepatic circulation of bile acids in mammals: form and functions
Hofmann, A. (2009) · Frontiers in Bioscience · doi:10.2741/3399 · Cited by 322
Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice
Maruyama, T., Tanaka, K., Suzuki, J., Miyoshi, H., Harada, N., Nakamura, T., Miyamoto, Y., Kanatani, A., & Tamai, Y. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06546 · Cited by 288
Zhang, Y., Kast-Woelbern, H. R., & Edwards, P. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209505200 · Cited by 286
Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease
Porez, G., Prawitt, J., Gross, B., & Staels, B. (2012) · Journal of Lipid Research · doi:10.1194/jlr.r024794 · Cited by 286
Bile Acid Metabolism and Signaling
Chiang, J. Y. L. (2013) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2013.tb00517.x · Cited by 279
Kohli, R., Bradley, D., Setchell, K. D., Eagon, J. C., Abumrad, N., & Klein, S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3736 · Cited by 265
Pellicciari, R., Gioiello, A., Macchiarulo, A., Thomas, C., Rosatelli, E., Natalini, B., Sardella, R., Pruzanski, M., Roda, A., Pastorini, E., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901390p · Cited by 260
Glucose Regulates the Expression of the Farnesoid X Receptor in Liver
Duran-Sandoval, D., Mautino, G., Martin, G., Percevault, F., Barbier, O., Fruchart, J.-C., Kuipers, F., & Staels, B. (2004) · Diabetes · doi:10.2337/diabetes.53.4.890 · Cited by 257
Self-citationWatanabe, M., Horai, Y., Houten, S. M., Morimoto, K., Sugizaki, T., Arita, E., Mataki, C., Sato, H., Tanigawara, Y., Schoonjans, K., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.248203 · Cited by 254
Effects of Diabetes Mellitus on Cholesterol Metabolism in Man
Bennion, L. J., & Grundy, S. M. (1977) · New England Journal of Medicine · doi:10.1056/nejm197706162962401 · Cited by 253
Fonseca, V. A., Rosenstock, J., Wang, A. C., Truitt, K. E., & Jones, M. R. (2008) · Diabetes Care · doi:10.2337/dc08-0283 · Cited by 246
Expression and activation of the farnesoid X receptor in the vasculature
Bishop-Bailey, D., Walsh, D. T., & Warner, T. D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400046101 · Cited by 242
Bile Acid Metabolism and the Pathogenesis of Type 2 Diabetes
Prawitt, J., Caron, S., & Staels, B. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0187-x · Cited by 238
How bile acids confer gut mucosal protection against bacteria
Hofmann, A. F., & Eckmann, L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600780103 · Cited by 237
Role of nuclear receptor SHP in metabolism and cancer
Zhang, Y., Hagedorn, C. H., & Wang, L. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.10.006 · Cited by 235
Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth
Dong, X., Park, S., Lin, X., Copps, K., Yi, X., & White, M. F. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25735 · Cited by 230
Zieve, F. J., Kalin, M. F., Schwartz, S. L., Jones, M. R., & Bailey, W. L. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.01.003 · Cited by 221
Gerhard, G. S., Styer, A. M., Wood, G. C., Roesch, S. L., Petrick, A. T., Gabrielsen, J., Strodel, W. E., Still, C. D., & Argyropoulos, G. (2013) · Diabetes Care · doi:10.2337/dc12-2255 · Cited by 220
FGF19 action in the brain induces insulin-independent glucose lowering
Morton, G. J., Matsen, M. E., Bracy, D. P., Meek, T. H., Nguyen, H. T., Stefanovski, D., Bergman, R. N., Wasserman, D. H., & Schwartz, M. W. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70710 · Cited by 219
Regulation of Bile Acid Synthesis by Fat-soluble Vitamins A and D
Schmidt, D. R., Holmstrom, S. R., Fon Tacer, K., Bookout, A. L., Kliewer, S. A., & Mangelsdorf, D. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.116004 · Cited by 213
Bays, H. E., Goldberg, R. B., Truitt, K. E., & Jones, M. R. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.18.1975 · Cited by 212
Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promoters
Huber, R. M., Murphy, K., Miao, B., Link, J. R., Cunningham, M. R., Rupar, M. J., Gunyuzlu, P. L., Haws, T. F., Kassam, A., Powell, F., et al. (2002) · Gene · doi:10.1016/s0378-1119(02)00557-7 · Cited by 210
FXR signaling in metabolic disease
Zhang, Y., & Edwards, P. A. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.015 · Cited by 209
Circulating Fibroblast Growth Factors as Metabolic Regulators—A Critical Appraisal
Angelin, B., Larsson, T. E., & Rudling, M. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.11.001 · Cited by 209
Brufau, G., Stellaard, F., Prado, K., Bloks, V. W., Jonkers, E., Boverhof, R., Kuipers, F., & Murphy, E. J. (2010) · Hepatology · doi:10.1002/hep.23831 · Cited by 198
Self-citationGoldberg, R. B. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.14.1531 · Cited by 197
Garg, A., & Grundy, S. M. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-6-199409150-00004 · Cited by 187
Steinert, R. E., Peterli, R., Keller, S., Meyer‐Gerspach, A. C., Drewe, J., Peters, T., & Beglinger, C. (2013) · Obesity · doi:10.1002/oby.20522 · Cited by 186
The bile acid membrane receptor TGR5: a valuable metabolic target
Pols, T. W. H., Noriega, L. G., Nomura, M., Auwerx, J., & Schoonjans, K. (2011) · Digestive Diseases · doi:10.1159/000324126 · Cited by 185
Metabolism of Cholesterol and Plasma Triglycerides in Nonketotic Diabetes Mellitus
Abrams, J. J., Ginsberg, H., & Grundy, S. M. (1982) · Diabetes · doi:10.2337/diab.31.10.903 · Cited by 185
Nuclear receptors in bile acid metabolism
Li, T., & Chiang, J. Y. L. (2013) · Drug Metabolism Reviews · doi:10.3109/03602532.2012.740048 · Cited by 176
Bile???Acid???Sequestrants???and???the???Treatment of Type??2??Diabetes??Mellitus
Staels, B., & Kuipers, F. (2007) · Drugs · doi:10.2165/00003495-200767100-00001 · Cited by 176
Self-citationTissue-specific mRNA Expression Profiles of Human Nuclear Receptor Subfamilies
Nishimura, M., Naito, S., & Yokoi, T. (2004) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.19.135 · Cited by 173
Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice
Potthoff, M. J., Potts, A., He, T., Duarte, J. A. G., Taussig, R., Mangelsdorf, D. J., Kliewer, S. A., & Burgess, S. C. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00400.2012 · Cited by 166
Trauner, M., Wagner, M., Fickert, P., & Zollner, G. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000155551.37266.26 · Cited by 164
Beysen, C., Murphy, E. J., Deines, K., Chan, M., Tsang, E., Glass, A., Turner, S. M., Protasio, J., Riiff, T., & Hellerstein, M. K. (2012) · Diabetologia · doi:10.1007/s00125-011-2382-3 · Cited by 163
Rizzo, G., Sante, M. D., Mencarelli, A., Renga, B., Gioiello, A., Pellicciari, R., & Fiorucci, S. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.023820 · Cited by 161
Impaired Generation of 12-Hydroxylated Bile Acids Links Hepatic Insulin Signaling with Dyslipidemia
Haeusler, R. A., Pratt–Hyatt, M., Welch, C. L., Klaassen, C. D., & Accili, D. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.11.010 · Cited by 158
Regulation of hepatic metabolic pathways by the orphan nuclear receptor SHP
Boulias, K., Katrakili, N., Bamberg, K., Underhill, P., Greenfield, A., & Talianidis, I. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600728 · Cited by 150
Nuclear receptors in human immune cells: Expression and correlations
Schote, A. B., Turner, J. D., Schiltz, J., & Muller, C. P. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.04.021 · Cited by 147
Downregulation of Endothelin-1 by Farnesoid X Receptor in Vascular Endothelial Cells
He, F., Li, J., Mu, Y., Kuruba, R., Ma, Z., Wilson, A. S., Alber, S. M., Jiang, Y., Stevens, T., Watkins, S. C., et al. (2005) · Circulation Research · doi:10.1161/01.res.0000200400.55539.85 · Cited by 144
Shah, M., Law, J. H., Micheletto, F., Sathananthan, M., Man, C. D., Cobelli, C., Rizza, R. A., Camilleri, M., Zinsmeister, A. R., & Vella, A. V. (2013) · Diabetes · doi:10.2337/db13-0954 · Cited by 143
Maternal cholestasis during pregnancy programs metabolic disease in offspring
Papacleovoulou, G., Abu‐Hayyeh, S., Nikolopoulou, E., Briz, Ó., Owen, B. M., Nikolova, V., Ovadia, C., Huang, X. B., Vääräsmäki, M., Baumann, M. U., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68927 · Cited by 140
Alterations of Hormonally Active Fibroblast Growth Factors after Roux-en-Y Gastric Bypass Surgery
Jansen, P. L. M., van Werven, J. R., Aarts, E. O., Berends, F. J., Janssen, I. M. C., Stoker, J., & Schaap, F. G. (2011) · Digestive Diseases · doi:10.1159/000324128 · Cited by 137
Loss of FXR Protects against Diet-Induced Obesity and Accelerates Liver Carcinogenesis in ob/ob Mice
Zhang, Y., Ge, X., Heemstra, L. A., Chen, W., Xu, J., Smith, J. L., Ma, H., Kasim, N., Edwards, P. A., & Novak, C. M. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1157 · Cited by 134
Wu, T., Bound, M. J., Standfield, S., Gedulin, B. R., Jones, K. L., Horowitz, M., & Rayner, C. K. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12043 · Cited by 132
Keitel, V., Ullmer, C., & Häussinger, D. (2010) · Biological Chemistry · doi:10.1515/bc.2010.077 · Cited by 129
Perspective: TGR5 (Gpbar-1) in liver physiology and disease
Keitel, V., & Häussinger, D. (2012) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2012.03.008 · Cited by 129
Roles of FGF19 in Liver MetabolismPreprint
Kır, S., Kliewer, S. A., & Mangelsdorf, D. J. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010710 · Cited by 128
Stellaard, F., Sackmann, M. F., Sauerbruch, T., & Paumgartner, G. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34446-1 · Cited by 120
Bile Acid Binding Resin Improves Metabolic Control through the Induction of Energy Expenditure
渡辺, 光., Morimoto, K., Houten, S. M., Kaneko-Iwasaki, N., Sugizaki, T., Horai, Y., Mataki, C., Sato, H., Murahashi, K., Arita, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038286 · Cited by 114
Shang, Q., Saumoy, M., Holst, J. J., Salen, G., & Xu, G. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00362.2009 · Cited by 111
Enteroendocrine secretion of gut hormones in diabetes, obesity and after bariatric surgery
Holst, J. J. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.09.014 · Cited by 111
Kemper, J. K. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.11.011 · Cited by 111
Nuclear Receptors as Drug Targets in Cholestatic Liver Diseases
Halilbasic, E., Baghdasaryan, A., & Trauner, M. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2012.12.001 · Cited by 110
Emerging role of fibroblast growth factors 15/19 and 21 as metabolic integrators in the liver
Cicione, C., Degirolamo, C., & Moschetta, A. (2012) · Hepatology · doi:10.1002/hep.25929 · Cited by 107
Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism
Hu, X., Bonde, Y., Eggertsen, G., & Rudling, M. J. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12140 · Cited by 106
Brufau, G., Groen, A. K., & Kuipers, F. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.181206 · Cited by 100
Self-citationHerrema, H., Meissner, M., van Dijk, T. H., Brufau, G., Boverhof, R., Oosterveer, M. H., Reijngoud, D., Müller, M. M., Stellaard, F., Groen, A. K., et al. (2009) · Hepatology · doi:10.1002/hep.23408 · Cited by 100
Self-citationAbdelkarim, M., Caron, S., Duhem, C., Prawitt, J., Dumont, J., Lucas, A., Bouchaert, E., Briand, O., Brozek, J., Kuipers, F., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.166231 · Cited by 99
Self-citationThe Effect of a Bile Acid Sequestrant on Glucose Metabolism in Subjects With Type 2 Diabetes
Smushkin, G., Sathananthan, M., Piccinini, F., Man, C. D., Law, J. H., Cobelli, C., Zinsmeister, A. R., Rizza, R. A., & Vella, A. V. (2012) · Diabetes · doi:10.2337/db12-0923 · Cited by 92
Host responses to the human microbiome
Bäckhed, F. (2012) · Nutrition Reviews · doi:10.1111/j.1753-4887.2012.00496.x · Cited by 89
Phosphorylation of Farnesoid X Receptor by Protein Kinase C Promotes Its Transcriptional Activity
Gineste, R., Sirvent, A., Paumelle, R., Helleboid, S., Aquilina, A., Darteil, R., Hum, D. W., Fruchart, J., & Staels, B. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0092 · Cited by 87
Reducing Cardiovascular Complications of Type 2 Diabetes by Targeting Multiple Risk Factors
Reasner, C. A. (2008) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31817ffe5a · Cited by 84
Berrabah, W., Aumercier, P., Gheeraert, C., Dehondt, H., Bouchaert, E., Alexandre, J., Ploton, M., Mazuy, C., Caron, S., Tailleux, A., et al. (2013) · Hepatology · doi:10.1002/hep.26710 · Cited by 80
Diet1 Functions in the FGF15/19 Enterohepatic Signaling Axis to Modulate Bile Acid and Lipid Levels
Vergnes, L., Lee, J. M., Chin, R. G., Auwerx, J. H., & Reue, K. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.007 · Cited by 79
Bjursell, M., Wedin, M., Admyre, T., Hermansson, M., Böttcher, G., Göransson, M., Lindén, D., Bamberg, K., Oscarsson, J., & Bohlooly‐Y, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064721 · Cited by 78
Lee, J., Seok, S., Yu, P., Kim, K., Smith, Z., Rivas‐Astroza, M., Zhong, S., & Kemper, J. K. (2012) · Hepatology · doi:10.1002/hep.25609 · Cited by 78
Plasma bile acids are not associated with energy metabolism in humans
Brufau, G., Bahr, M. J., Staels, B., Claudel, T., Ockenga, J., Böker, K. H. W., Murphy, E. J., Prado, K. B., Stellaard, F., Manns, M. P., et al. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-73 · Cited by 77
Self-citationPlasma Bile Acids Are Associated with Energy Expenditure and Thyroid Function in Humans
Ockenga, J., Valentini, L., Schuetz, T., Wohlgemuth, F., Glaeser, S., Omar, A., Kasim, E., DuPlessis, D., Featherstone, K., Davis, J. R., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2329 · Cited by 74
Bile lipid composition and bile acid pool size in diabetes
de Leòn, M. P., Ferenderes, R., & Carulli, N. (1978) · Digestive Diseases and Sciences · doi:10.1007/bf01072357 · Cited by 71
Jones, S. A. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0887-1_11 · Cited by 70
Bisschop, P. H. L. T., Bandsma, R., Stellaard, F., ter Harmsel, A., Meijer, A. J., Sauerwein, H. P., Kuipers, F., & Romijn, J. A. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.4.570 · Cited by 68
Self-citationFibroblast growth factor-19 levels in type 2 diabetic patients with metabolic syndrome.
Barutçuoğlu, B., Başol, G., Çakır, Y., Çetinkalp, Ş., Parıldar, Z., Kabaroğlu, C., Ozmen, D., MUTAF, I., & Bayındır, O. (2011) · PubMed · Cited by 67
Targeting Farnesoid-X-Receptor: From Medicinal Chemistry to Disease Treatment
Fiorucci, S., Mencarelli, A., Distrutti, E., et al. (2009) · Current Medicinal Chemistry · doi:10.2174/092986710790112666 · Cited by 61
Altered bile acid profiles in duodenal bile and urine in diabetic subjects
ANDERSÉN, E., Karlaganis, G., & Sjövall, J. (1988) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1988.tb02408.x · Cited by 59
Svensson, P., Olsson, M. M., Andersson‐Assarsson, J. C., Taube, M., Pereira, M. J., Froguel, P., & Jacobson, P. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.03.031 · Cited by 49
Farnesoid X Receptor: From Medicinal Chemistry To Clinical Applications
Fiorucci, S., Mencarelli, A., Distrutti, E., & Zampella, A. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.41 · Cited by 48
Schwartz, S. L., Lai, Y., Xu, J., Abby, S. L., Misir, S., Jones, M. R., & Nagendran, S. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2009.0049 · Cited by 47
Thomas, A., Hart, S. N., Li, G., Lü, H., Fang, Y., Fang, J., Zhong, X., & Guo, G. L. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1006-7 · Cited by 47
Fang, Q., Li, H., Song, Q., Yang, W. J., Hou, X., Ma, X., Lu, J., Xu, A., & Jia, W. (2013) · Diabetes Care · doi:10.2337/dc12-1766 · Cited by 47
The farnesoid X receptor: a novel drug target?
Claudel, T., Sturm, E., Kuipers, F., & Staels, B. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.9.1135 · Cited by 44
Self-citationHolst, J. J., & McGill, M. A. (2011) · Clinical Drug Investigation · doi:10.2165/11595370-000000000-00000 · Cited by 44
Lundåsen, T., Andersson, E.-M., Snaith, M. R., Lindmark, H., Lundberg, J., Östlund‐Lindqvist, A., Angelin, B., & Rudling, M. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037787 · Cited by 41
Lipid composition of bile in diabetics and obesity-matched controls.
Haber, G. B., & Heaton, K. W. (1979) · Gut · doi:10.1136/gut.20.6.518 · Cited by 41
Colesevelam for type 2 diabetes mellitus
Ooi, C. P., & Loke, S. C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009361.pub2 · Cited by 39
Rosenstock, J., Fonseca, V. A., Garvey, W. T., Goldberg, R. B., Handelsman, Y., Abby, S. L., Lai, Y.-L., Jin, X., Misir, S., Nagendran, S., et al. (2010) · Endocrine Practice · doi:10.4158/ep10130.or · Cited by 35
Colesevelam HCl effects on atherogenic lipoprotein subclasses in subjects with type 2 diabetes
Rosenson, R. S., Abby, S. L., & Jones, M. R. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.09.026 · Cited by 34
Bochkis, I. M., Shin, S., & Kaestner, K. H. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.08.005 · Cited by 30
Fish Oil Increases Bile Acid Synthesis in Male Patients with Hypertriglyceridemia
Jonkers, I. J. A. M., Smelt, A. H. M., Princen, H. M. G., et al. (2006) · Journal of Nutrition · doi:10.1093/jn/136.4.987 · Cited by 30
Hofmann, A. F. (2010) · Hepatology · doi:10.1002/hep.24100 · Cited by 28
Targeting Nuclear Bile Acid Receptors for Liver Disease
Trauner, M., Baghdasaryan, A., Claudel, T., Fickert, P., Halilbasic, E., Moustafa, T., & Zollner, G. (2011) · Digestive Diseases · doi:10.1159/000324141 · Cited by 26
Meissner, M., Herrema, H., van Dijk, T. H., Gerding, A., Havinga, R., Boer, T. S., Müller, M. M., Reijngoud, D., Groen, A. K., & Kuipers, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024564 · Cited by 25
Self-citationMissing link identified: GpBAR1 is a neuronal bile acid receptor
Keely, S. J. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01528.x · Cited by 14
Cited by
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
Wahlström, A., Sayin, S. I., Marschall, H.-U., & Bäckhed, F. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.005 · Cited by 2,851
Gut microbiome and health: mechanistic insights
de Vos, W. M., Tilg, H., Van Hul, M., & Cani, P. D. (2022) · Gut · doi:10.1136/gutjnl-2021-326789 · Cited by 2,388
Lipotoxicity and the gut-liver axis in NASH pathogenesis
Marra, F., & Svegliati-Baroni, G. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.014 · Cited by 847
The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments
Targher, G., Corey, K. E., Byrne, C. D., & Roden, M. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00448-y · Cited by 850
Intestinal transport and metabolism of bile acids
Dawson, P. A., & Karpen, S. J. (2015) · Journal of Lipid Research · doi:10.1194/jlr.r054114 · Cited by 598
Metadata
- Authors
- Kuipers, F., Bloks, V. W., & Groen, A. K.
- Venue
- Nature Reviews Endocrinology
- Published
- 2014-05-13
- Volume
- 10
- Issue
- 8
- Pages
- 488-498
- ISSN
- 1759-5029 (ISSN-L)
- 1759-5037
- OpenAlex
- W1969668125
- Cited by
- 454
- References
- 136
- FWCI
- 4.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.